Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

ConditionsIn Vitro Fertilization (IVF)Embryo Transfer

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexFemale

Age25-44

SponsorNational Taiwan University Hospital

About this trial

Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

GnRH agonist

Treatment groups

170 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

National Taiwan University Hospital

Lead sponsor

Source ClinicalTrials.gov